Application of Artificial Neural Networks to Investigate One-Carbon Metabolism in Alzheimer's Disease and Healthy Matched Individuals

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Coppedè, Fabio ^a   Grossi, Enzo ^b,c   Buscema, Massimo ^c,d   Migliore, Lucia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Bracco Foundation   (Italy)

^c Semeion centro ricerche di scienze della communicazione   (Italy)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CARBON METABOLISM; CASE CONTROL STUDY; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONNECTOME; CONTROLLED STUDY; DEMENTIA; DNA SYNTHESIS; EVOLUTIONARY ALGORITHM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; METHYLATION; RISK FACTOR; SEMANTICS;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); REPRODUCIBILITY OF RESULTS;

EID: 84881510899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074012     Document Type: Article

References (69)

1. Van Dam F, Van Gool WA, (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr 48: 425-430. doi:10.1016/j.archger.2008.03.009. PubMed: 18479766.
2. Coppedè F, (2010) One-carbon metabolism and Alzheimer's disease: focus on epigenetics. Curr Genomics 11: 246-260. doi:10.2174/138920210791233090. PubMed: 21119889.
3. Wald DS, Kasturiratne A, Simmonds M, (2011) Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement 7: 412-417. doi:10.1016/j.jalz.2011.05.1198. PubMed: 21784352.
4. Ho RC, Cheung MW, Fu E, Win HH, Zaw MH, et al. (2011) Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry 19: 607-617. doi:10.1097/JGP.0b013e3181f17eed. PubMed: 21705865.
5. Regland B, Abrahamsson L, Gottfries CG, Magnus E, (1990) Vitamin B12 analogues, homocysteine, methylmalonic acid, and transcobalamins in the study of vitamin B12 deficiency in primary degenerative dementia. Dement Geriatr Cogn Disord 1: 272-277. doi:10.1159/000107152.
6. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, et al. (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80: 114-122. PubMed: 15213037.
7. Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, et al. (2011) Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis 27: 909-922. PubMed: 21891867.
8. Coppedè F, Tannorella P, Pezzini I, Migheli F, Ricci G, et al. (2012) Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. Antioxid Redox Signal 17: 195-204. doi:10.1089/ars.2011.4368. PubMed: 22034983.
9. Zhuo JM, Wang H, Praticò D, (2011) Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32: 562-571. doi:10.1016/j.tips.2011.05.003. PubMed: 21684021.
10. Huang CW, Chang WN, Huang SH, Lui CC, Chen NC, et al. (2013) Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia. Eur J Neurol (2013) PubMed: 23581395.
11. Hinterberger M, Fischer P, (2013) Folate and Alzheimer: when time matters. J Neural Transm 120: 211-224. doi:10.1007/s00702-012-0822-y. PubMed: 22627695.
12. Moore E, Mander A, Ames D, Carne R, Sanders K, et al. (2012) Cognitive impairment and vitamin B12: a review. Int Psychogeriatr (2012) PubMed: 22221769.
13. Cacciapuoti F, (2012) Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease. J Thromb Thrombolysis (In press).
14. Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, et al. (2010) Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLOS Genet 6: e1001130. PubMed: 20885792.
15. Hua Y, Zhao H, Kong Y, Ye M, (2011) Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. Int J Neurosci 121: 462-471. doi:10.3109/00207454.2011.578778. PubMed: 21663380.
16. Bi XH, Zhao HL, Zhang ZX, Zhang JW, (2009) Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol Aging 30: 1601-1607. doi:10.1016/j.neurobiolaging.2007.12.010. PubMed: 18258338.
17. Kageyama M, Hiraoka M, Kagawa Y, (2008) Relationship between genetic polymorphism, serum folate and homocysteine in Alzheimer's disease. Asia Pac J Public Health 20: 111-117. PubMed: 19533869.
18. Coppedè F, Grossi E, Migheli F, Migliore L, (2010) Polymorphisms in Folate-Metabolizing Genes, Chromosome Damage, and Risk of Down Syndrome in Italian Women: Identification of Key Factors Using Artificial Neural Networks. BMC Med Genomics 3: 42. doi:10.1186/1755-8794-3-42. PubMed: 20868477.
19. Penco S, Grossi E, Cheng S, Intraligi M, Maurelli G, et al. (2005) Assessment of the Role of Genetic Polymorphism in Venous Thrombosis Through Artificial Neural Networks. Ann Hum Genet 69: 693-706. doi:10.1111/j.1529-8817.2005.00206.x. PubMed: 16266408.
20. Lisboa PJC, (2002) A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Netw 15: 11-39. doi:10.1016/S0893-6080(01)00111-3. PubMed: 11958484.
21. Grossi E, Mancini A, Buscema M, (2007) International experience on the use of artificial neural networks in gastroenterology. Dig Liver Dis 39: 278-285. doi:10.1016/j.dld.2006.10.003. PubMed: 17275425.
22. Tabaton M, Odetti P, Cammarata S, Borghi R, Monacelli F, et al. (2010) Artificial Neural Networks Identify the Predictive Values of Risk Factors on the Conversion of Amnestic Mild Cognitive Impairment. J Alzheimers Dis 19: 1035-1040. PubMed: 20157257.
23. Penco S, Buscema M, Patrosso MC, Marocchi A, Grossi E, (2008) New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. BMC Bioinformatics 9: 254. doi:10.1186/1471-2105-9-254. PubMed: 18513389.
24. Buscema M, Penco S, Grossi E, (2012) A Novel Mathematical Approach to Define the Genes/SNPs Conferring Risk or Protection in Sporadic Amyotrophic Lateral Sclerosis Based on Auto Contractive Map Neural Networks and Graph Theory. Neurol Res Int, 2012(2012): 478560. PubMed: 22934166.
25. Tarlarini C, Penco S, Conio M, Grossi E, (2012) Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis. Clin Exp Gastroenterol 5: 159-166. PubMed: 22893750.
26. Franceschi M, Caffarra P, Savarè R, Cerutti R, Grossi E, et al. (2011) Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer's disease. Behav Neurol 24: 149-158. PubMed: 21606576.
27. Coppedè F, Zitarosa MT, Migheli F, Lo Gerfo A, Bagnoli S, et al. (2012) DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr Alzheimer Res 9: 550-554. PubMed: 22272627.
28. Buscema M, Grossi E, (2008) The semantic connectivity map: an adapting self organising knowledge discovery method in databases. Experience in gastro-oesophageal reflux disease. Int J Data Min Bioinform 2: 362-404. doi:10.1504/IJDMB.2008.022159. PubMed: 19216342.
29. Buscema M, Grossi E, Snowdon D, Antuono P, (2008) Auto-Contractive Maps: an artificial adaptive system for data mining. An Appl Alzheimers Dis Curr Alzheimers Res 5: 481-498.
30. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269. doi:10.1016/j.jalz.2011.05.750. PubMed: 21514250.
31. Freund Y, Schapire RE, (1996) Experiments with a new boosting algorithm. In: Machine Learning: Proceedings of the Thirteenth International Conference. pp. pp. 325-332.
32. Breiman L, (1996) Bagging predictors. Mach Learn 24: 123-140. doi:10.1023/A:1018054314350.
33. Breiman L, (2001) Random forests. Mach Learn 45: 5-32. doi:10.1023/A:1010933404324.
34. Friedman N, Geiger D, Goldszmidt M, (1997) Bayesian Network Classifiers. Mach Learn 29: 131-163. doi:10.1023/A:1007465528199.
35. Domingos P, Pazzani M, (1997) Beyond independence: Conditions for the optimality of the simple Bayesian classifier. Mach Learn 29: 103-130. doi:10.1023/A:1007413511361.
36. Aha DW, Kibler D, Albert MK, (1991) Instance-based learning algorithms. Mach Learn 6: 37-66. doi:10.1023/A:1022689900470.
37. Quinlan JR, (1996) Improve use of continuous attributes in C4.5. J Artif Intell Res 4: 77-90.
38. Cleary JG, Trigg LE, (1995) K*: an instance-based learner using an entropic distance measure.
39. le Cessie S, van Houwelingen JC, (1992) Ridge Estimators in Logistic Regression. Appl Stat 41: 191-201. doi:10.2307/2347628.
40. Friedman J, Hastie T, Tibshirani R, (2000) Additive Logistic Regression: a Statistical View of Boosting. Ann Statist 28: 337-407. doi:10.1214/aos/1016218222.
41. Rumelhart DE, Hinton GE, Williams RJ, (1986) Learning internal representations by error propagation. In: Rumelhart DE, McClelland JL, eds. Parallel distributed processing, Foundations, Explorations in the Microstructure of Cognition. Cambridge: The MIT Press. pp pp. 318-362.
42. Rodriguez JJ, Kuncheva LI, Alonso CJ, (2006) Rotation Forest: A new classifier ensemble method. IEEE, Trans Pattern Anal Mach Intell 28: 1619-1630.
43. Keerthi SS, Shevade SK, Bhattacharyya C, Murthy KRK, (2001) Improvements to Platt's SMO algorithm for SVM classifier design. Neural Comput 13: 637-649. doi:10.1162/089976601300014493.
44. Buscema M, (1998) Back propagation neural networks. Subst Use Misuse 33: 233-270. doi:10.3109/10826089809115863. PubMed: 9516725.
45. Buscema M, Terzi S, Breda M, (2006) Using sinusoidal modulated weights improve feed-forward neural networks performances in classification and functional approximation problems. WSEAS Trans Inf Sci Appl 3: 885-893.
46. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH, (2009) The WEKA data mining software: an update. SIGKDD Explor Newsl 11: 10-18. doi:10.1145/1656274.1656278.
47. Brill FZ, Brown DE, Martin WN, (1992) Fast Genetic Selection of Features for Neural Network Classifiers. IEEE Trans Neural Netw 3: 324-328. doi:10.1109/72.125874. PubMed: 18276434.
48. Kudo M, Sklansky J, (2000) Comparison of Algorithms That Select Features for Pattern Classifiers. Pattern Recognit 33: 25-41. doi:10.1016/S0031-3203(99)00041-2.
49. Gonzalez A, Perez R, (2001) Selection of Relevant Features in a Fuzzy Genetic Learning Algorithm. IEEE Trans Syst Man Cybern B Cybern 31: 417-425. doi:10.1109/3477.931534. PubMed: 18244806.
50. Leahy P, Kiely G, Corcoran G, (2008) Structural Optimisation and Input Selection of an Artificial Neural Network for River Level Prediction. J Hydrol 355: 192-201. doi:10.1016/j.jhydrol.2008.03.017.
51. Buscema M, Breda M, Lodwick W, (2013) Training With Input Selection and Testing (TWIST) algorithm: a significant advance in pattern recognition performance of machine learning. J Intell Learn Syst Appl 5: 29-38.
52. Buscema M, (2004) Genetic Doping Algorithm (GenD): Theory and Application. Expert Syst 21: 63-79. doi:10.1111/j.1468-0394.2004.00264.x.
53. Buscema M, Grossi E, Intraligi M, Garbagna N, Andriulli A, et al. (2005) An Optimized Experimental Protocol Based on Neuro-Evolutionary Algorithms. Application to the Classification of Dyspeptic Patients and to the Prediction of the Effectiveness of Their Treatment. Artif Intell Med 34: 279-305. doi:10.1016/j.artmed.2004.12.001. PubMed: 16023564.
54. Lahner E, Intraligi M, Buscema M, Centanni M, Vannella L, et al. (2008) Artificial Neural Networks in the Recognition of the Presence of Thyroid Disease in Patients with Atrophic Body Gastritis. World J Gastroenterol 14: 563-568. doi:10.3748/wjg.14.563. PubMed: 18203288.
55. Buri L, Hassan C, Bersani G, Anti M, Bianco MA,et al (2010) Appropriateness Guidelines and Predictive Rules to Select Patients for Upper Endoscopy: A Nationwide Multicenter Study. Am J Gastroenterol 105: 1327-1337. doi:10.1038/ajg.2009.675. PubMed: 20029414.
56. Street ME, Grossi E, Volta C, Faleschini E, Bernasconi S, (2008) Placental Determinants of Fetal Growth: Identification of Key Factors in the Insulin-Like Growth Factor and Cytokine Systems Using Artificial Neural Networks. BMC Pediatr 8: 24. doi:10.1186/1471-2431-8-24. PubMed: 18559101.
57. Buscema M, Grossi E, Capriotti M, Babiloni C, Rossini PM, (2010) The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy. Curr Alzheimer Res 7: 173-187.
58. Rotondano G, Cipolletta L, Grossi E, Koch M, Intraligi M, et al. (2011) Artificial Neural Networks Accurately Predict Mortality in Patients with Non variceal Upper GI Bleeding. Gastrointest Endoscop 73: 218-226. doi:10.1016/j.gie.2010.10.006.
59. Pace F, Riegler G, de Leone A, Pace M, Cestari R, et al. (2010) Is It Possible to Clinically Differentiate Erosive from Non erosive Reflux Disease Patients? A Study Using an Artificial Neural Networks-Assisted Algorithm. Eur J Gastroenterol Hepatol 22: 1163-1168. doi:10.1097/MEG.0b013e32833a88b8. PubMed: 20526203.
60. Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, et al. (2013) A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. Immun Ageing 10: 1. doi:10.1186/1742-4933-10-1. PubMed: 23305498.
61. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE, (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39: 17-23. doi:10.1038/ng1934. PubMed: 17192785.
62. Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, et al. (2010) Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. J Alzheimers Dis 20: 1181-1188. PubMed: 20413850.
63. Gupta A, Bisht B, Dey CS, (2011) Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology 60: 910-920. doi:10.1016/j.neuropharm.2011.01.033. PubMed: 21277873.
64. Imfeld P, Bodmer M, Jick SS, Meier CR, (2012) Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc 60: 916-921. doi:10.1111/j.1532-5415.2012.03916.x. PubMed: 22458300.
65. Corominas-Faja B, Quirantes-Piné R, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, et al. (2012) Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) 4: 480-498.
66. Menendez JA, Joven J, (2012) One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metformin. Aging (Albany NY) 4(12):: 894-898. PubMed: 23525940.
67. Parachikova A, Green KN, Hendrix C, LaFerla FM, (2010) Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PLOS ONE 5: e14015. doi:10.1371/journal.pone.0014015. PubMed: 21103342.
68. Hinterberger M, Zehetmayer S, Jungwirth S, Huber K, Krugluger W, et al. (2013) High cortisol and low folate are the only routine blood tests predicting probable Alzheimer's disease after age 75-results of the Vienna Transdanube Aging Study. J Am Geriatr Soc 61(4):: 648-651. doi:10.1111/jgs.12178. PubMed: 23581921.
69. Park LK, Friso S, Choi SW, (2012) Nutritional influences on epigenetics and age-related disease. Proc Nutr Soc 71: 75-83. doi:10.1017/S0029665112001322. PubMed: 22051144.